Table 1.
Structural and vascular biomarkers | Imaging technique | Quantification possible? | Reason in favor of use | Principal limitation |
---|---|---|---|---|
Carotid morphology |
CTA MRI |
NASCET criteria |
Anatomical structures variance assessment Plaque analysis |
Over estimation of calcification Under estimation of calcification |
Carotid blood flow velocity | DUS |
PVS > 125 cm/s EDV > 140 cm/s |
Real-time hemodynamical information | Investigator dependent |
Cerebral morphology | CTA or MRI | No |
Subacute and chronic ischemic lesion detection Anatomical structures variance assessment |
Image resolution limits the visualization of smaller vessel |
Cerebral blood flow velocity | TCD | No | Measurement the cerebral reserve capacity | 20% of patients lack of TCD window |
Retinal neuronal changes | ||||
Macular RNFL thinning | OCT | Yes | Quantification of retinal neural damage | Lack of information on retinal blood flow |
Peripapillar RNFL thinning | Yes | |||
GCL-IPL thinning | Yes | |||
Retinal vascular changes | ||||
VD decrease | OCTA | Yes | Quantification of retinal capillary blood-flow | Not part of routine clinical practice |
FAZ enlargement | Yes |
DUS duplex ultrasound, PVS peak systolic velocity, EDV end diastolic velocity, CTA computed tomography angiography, MRI magnetic resonance imaging, TCD transcranial Doppler, OCT optical coherence tomography, OCTA optical coherence tomography angiography, RNFL retinal nerve fiber layer, GCL-ICL ganglion cell layer-inner plexiform layer, VD vessel density, FAZ fovea avascular zone